GLP-1 RA Drug NAION Cases: Possible Drug Injury Lawsuits We are investigating possible drug injury lawsuits where people using glucagon-like peptide-I receptor agonist (GLP-1 RA) drugs were diagnosed with non-arteritic anterior ischemic optic neuropathy (NAION), resulting in vision loss or blindness. Those GLP-1 RA drug NAION cases involve these … [Read more...]
Increased Risk of NAION Associated With Ozempic and Mounjaro
A 2025 medical study concluded that there is an increased risk of NAION associated with Ozempic and Mounjaro. In more detail, the researchers considered whether treatment with either Ozempic (semaglutide) or Mounjaro (tirzepatide) is associated with an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION) when compared to … [Read more...]
NAION With Mounjaro and Zepbound Being Investigated
The FDA is investigating the possible connection of NAION with Mounjaro and Zepbound, according to “October – December 2024 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)”. During the past year, we have written about the vision loss side effect NAION (non-arteritic … [Read more...]